Pathogenetic Reasons for Usage of Piascledine for the Treatment of Osteoarthritis

I.Yu. Holovach


Osteoarthritis is nowadays considered not as a degenerative process but as a pathological remodeling of various tissues of a joint (bone, cartilaginous and synovial tissue) that is associated with and determined by pro-inflammatory mediators with further development of metabolic and functional dysfunction of all joint structures. Interleukin 1 plays a particular role in the pathogenesis of osteoarthritis. It affects metabolism of articular cartilage and sunchondral bone in different ways. The family of transforming growth factors also plays an important role, namely transforming growth factor β. That is why they are important targets for therapeutic strategy in osteoarthritis. Discovery of molecular mechanisms of cartilage degradation and detailing of the reasons of persistent inflammation in joint tissues led to the development of the agents with symptoms and structure modifying properties that affect the course and rate of progression of the disease. According to ЕULAR 2003 recommendations only 5 agents have symptom modifying action, particularly chondroitin sulfate, glucosamine sulphate, diacerein, hyaluronic acid and Piascledine. The last agent is of great interest due to its anticytolytic action. The paper deals with the experimental proves for positive effects of Piascledine on the concentration of pro-inflammatory cytokines as well as the results of clinical studies of high efficiency of the agent with symptoms and structure modifying properties for the treatment of osteoarthritis.


osteoarthritis; pathogenesis; inflammation; pro-inflammatory cytokines; Piascledine


Бадокин В.В. Пиаскледин — хондропротективный препарат с антицитокиновой активностью // Consilium Medicum. — 2007. — № 8. — С. 145-150.

Бадокин В.В. Результаты многоцентрового исследования по оценке эффективности и переносимости Пиаскледина // Эффективная фармакотерапия. — 2011. — № 39. — С. 6-12.

Балабанова Р.М. Новый подход к лечению остеоартроза как хронического воспалительного заболевания // Современная ревматология. — 2013. — № 2. — С. 95-98.

Борткевич О.П. Ефективність препарату Піаскледин® 300 у лікуванні пацієнтів з остеоартрозом: доведено в дослідженнях, підтверджено європейською практикою // Український ревматологічний журнал. — 2015. — № 1 (59). — С. 61-65.

Головач И.Ю. Остеоартрит: фундаментальные и прикладные аспекты этиопатогенеза заболевания. Ничего не стоит на месте // Український ревматологічний журнал. — 2014. — № 2 (56). — С. 4-11.

Журавльова Л.В., Олійник М.О. Роль прозапальних цитокінів у розвитку остеоартрозу та цукрового діабету ІІ типу // Український ревматологічний журнал. — 2015. — № 2 (60). — C. 31-35.

Широкова Л.Ю., Носков С.М., Паруля О.М. и др. Роль цитокинов в патогенезе остеоартроза // Цитокины и воспаление. — 2010. — № 4. — С. 16-19.

Шуба Н.М., Воронова Т.Д., Тарасенко Т.М., Крилова А.С. Нові аспекти патогенезу остеоартрозу та шляхи його корекції // Український ревматологічний журнал. — 2012. — № 1 (47). — С. 51-58.

Altinel L., Saritas Z.K., Kose K.C. et al. Treatment with unsaponifiable extracts of avocado and soy bean increases TGF-beta1 and TGF-beta2 levels in canine joint fluid // Tohoku J. Exp. Med. — 2007. — Vol. 211 (2). — P. 181-186.

Au R.Y., Al-Talib T.K., Au A.Y., Phan P.V., Frondoza C.G. Avocado soybean unsaponifiables (ASU) suppress TNF-alpha, IL-1beta, COX-2, iNOS gene expression, and prostaglandin E2 and nitric oxide production in articular chondrocytes and monocyte/macrophages // Osteoarthritis Cartilage. — 2007. — Vol. 15 (11). — P. 1249-1255.

Berenbaum F. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!) // Osteoarthritis Cartilage. — 2013. — Vol. 21. — P. 16-21.

Boileau С., Martel-Pelletier J., Caron J. et al. Protective effects of total fraction of avocado/soybean unsaponifiables on the structural changes in experimental dog osteoarthritis: inhibition of nitric oxide synthase and matrix metalloproteinase-13 // Arthritis Res. Therapy. — 2009. — Vol. 11. — R41.

Bouic P.J. The role of phitosterols and phitosterolins in immune modulation: a review of the past 10 years // Curr. Opin. Clin. Nutr. Metab Care. — 2001. — Vol. 4. — Р. 471-475.

Воumediene K., Felisaz P., Bogdanowicz P. et al. Avocado/soybean unsopanifiable enhance the eхpression of transforming growth β1 и β2 in cultured articular chondrocytes // Arthritis Rheum. — 1999. — Vol. 42. — P. 148-156.

Bush J.R., Beier F. TGF-β and osteoarthritis — the good and the bad // Nature Med. — 2013. — Vol. 19. — P. 667-669.

Case J.P., Baliunas A.J., Block J.A. Lack of efficacy of acetaminophen in treating symptomatic knee osteoarthritis: a randomized, double-blind, placebo-controlled comparison trial with diclofenac sodium // Arch. Intern. Med. — 2003. — Vol. 163. — P. 169-178.

Henrotin Y.E., Labasse A.H., Jaspar J.M. et al. Effects of three avocado/soybean unsaponifiable mixtures on metalloproteinases, cytokines and prostaglandin E2 production by human articular chondrocytes // Clin. Rheum. — 1998. — Vol. 17. — P. 31-39.

Henrotin Y.E., Sanchez C., Deberg M.A. et al. Avocado/soybean unsaponifiables increase aggrecan synthesis and reduce catabolic and proinflammatory mediator production by human osteoarthritic chondrocytes // J. Rheumatol. — 2003. — Vol. 30 (8). — P. 1825-34.

Jordan K.M., Arden N.K., Doherty M. et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT) // Ann. Rheum. Dis. — 2003. — Vol. 62 (12). — P. 1145-1155.

Kraan van der P.M., Davidson Blaney E.N., Blom A. TGF-beta signaling in chondrocyte terminal differentiation and osteoarthritis // Ostaiarthritis Cartilage. — 2009. — Vol. 17 (12). — P.1539-1545.

Kut-Lasserre C., Miller C.C., Ejei A.L. et al. Effect of avocado and soybean unsaponifiables on gelatinase A (MMP-2), stromelisin 1 (MMP-3) and tissue inhibitors of matrix metalloproteinase (TIMP-1 and TIMP-2) secretion by human fibroblasts in culture // J. Periodontol. — 2001. — Vol. 72. — Р. 1685-1694.

Loeser R.F., Goldrina S.R., Scanzello C.R. et al. Osteoarthritis: A Disease of the Joint as an Organ // Arthritis Rheum. — 2012. — Vol. 64 (6). — P. 1697-1707.

Zorn J. New aspects in rheumatism therapy: experiences with a sitosterin preparation in chronic polyarthritis // Med. Welt. — 1981. — Vol. 32. — Р. 135-138.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.


© Publishing House Zaslavsky, 1997-2019


   Seo анализ сайта